These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36812661)

  • 41. Phase IIa study of the CD19 antibody MOR208 in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma.
    Jurczak W; Zinzani PL; Gaidano G; Goy A; Provencio M; Nagy Z; Robak T; Maddocks K; Buske C; Ambarkhane S; Winderlich M; Dirnberger-Hertweck M; Korolkiewicz R; Blum KA
    Ann Oncol; 2018 May; 29(5):1266-1272. PubMed ID: 29444231
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rituximab is not associated with increased risk of second primary malignancies in Israeli patients with diffuse large B cell lymphoma treated with RCHOP regimen.
    Neeman Y; Perry C; Silverman B; Waintraub N; Avivi I
    Leuk Lymphoma; 2020 Nov; 61(11):2638-2644. PubMed ID: 32611210
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characteristics of Central Nervous System (CNS) Involvement in Children With Non-Hodgkin's Lymphoma (NHL) and the Diagnostic Value of CSF Flow Cytometry in CNS Positive Disease.
    Huang S; Jin L; Yang J; Duan Y; Zhang M; Zhou C; Zhang YH
    Technol Cancer Res Treat; 2021; 20():15330338211016372. PubMed ID: 34060372
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
    Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
    Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes.
    Herr MM; Schonfeld SJ; Dores GM; Engels EA; Tucker MA; Curtis RE; Morton LM
    Blood Adv; 2019 Jul; 3(13):1961-1969. PubMed ID: 31262739
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inferior survival and frequent hepatic dysfunction in non-Hodgkin's lymphoma patients with HBV infection: a systematic review and meta-analysis.
    Zhang MY; Gao F; Zhao YW; Ni BW; Huang HH; Hou J
    Hematology; 2022 Dec; 27(1):70-79. PubMed ID: 34957924
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Second primary malignancies after treatment for malignant lymphoma.
    Okines A; Thomson CS; Radstone CR; Horsman JM; Hancock BW
    Br J Cancer; 2005 Aug; 93(4):418-24. PubMed ID: 16106249
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low grade non-Hodgkin's lymphoma after high grade non-Hodgkin's lymphoma in a child with ataxia telangiectasia.
    Chen KT
    Cancer; 1994 Sep; 74(5):1649-50. PubMed ID: 8062199
    [No Abstract]   [Full Text] [Related]  

  • 49. Incidence and epidemiology of non-Hodgkin lymphoma and risk of second malignancy among 22 466 survivors in Israel with 30 years of follow-up.
    Tadmor T; Liphshitz I; Silverman B; Polliack A
    Hematol Oncol; 2017 Dec; 35(4):599-607. PubMed ID: 27238496
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gemcitabine, ifosfamide, oxaliplatin and rituximab (R-GIFOX), a new effective cytoreductive/mobilizing salvage regimen for relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a pilot study.
    Corazzelli G; Russo F; Capobianco G; Marcacci G; Della Cioppa P; Pinto A
    Ann Oncol; 2006 May; 17 Suppl 4():iv18-24. PubMed ID: 16702180
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Melanoma in patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma.
    Famenini S; Martires KJ; Zhou H; Xavier MF; Wu JJ
    J Am Acad Dermatol; 2015 Jan; 72(1):78-84. PubMed ID: 25440434
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Composite lymphoma. A clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma.
    Gonzalez CL; Medeiros LJ; Jaffe ES
    Am J Clin Pathol; 1991 Jul; 96(1):81-9. PubMed ID: 2069139
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lifetime risks of second primary malignancies after pediatric Hodgkin lymphoma and non-Hodgkin lymphoma.
    Wang L; Zheng Y; Luo R; Kang K; Niedermann G; Zhao A; Wu Y
    J Cancer Res Clin Oncol; 2024 Jan; 150(2):41. PubMed ID: 38280006
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Secondary non-Hodgkin's lymphoma after treatment for childhood cancer.
    Eguiguren JM; Ribeiro RC; Pui CH; Hancock ML; Pratt CB; Head DR; Crist WM
    Leukemia; 1991 Oct; 5(10):908-11. PubMed ID: 1961025
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome.
    Mauch PM; Kalish LA; Marcus KC; Coleman CN; Shulman LN; Krill E; Come S; Silver B; Canellos GP; Tarbell NJ
    Blood; 1996 May; 87(9):3625-32. PubMed ID: 8611686
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical and pathological reassessment of 493 cases of non-Hodgkin's lymphomas according to current WHO classification of lymphoid neoplasms].
    Xiao C; Su ZL; Wu QL; Gao HY; Fang JC; Xia ZJ; Guan ZZ
    Zhonghua Bing Li Xue Za Zhi; 2005 Jan; 34(1):22-7. PubMed ID: 15796877
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
    Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A
    J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anthropometric characteristics, physical activity, and risk of non-Hodgkin's lymphoma subtypes and B-cell chronic lymphocytic leukemia: a prospective study.
    Cerhan JR; Janney CA; Vachon CM; Habermann TM; Kay NE; Potter JD; Sellers TA; Folsom AR
    Am J Epidemiol; 2002 Sep; 156(6):527-35. PubMed ID: 12226000
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.
    Reiter A; Schrappe M; Parwaresch R; Henze G; Müller-Weihrich S; Sauter S; Sykora KW; Ludwig WD; Gadner H; Riehm H
    J Clin Oncol; 1995 Feb; 13(2):359-72. PubMed ID: 7844597
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Non-Hodgkin's lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish Lymphoma Study Group.
    d'Amore F; Brincker H; Grønbaek K; Thorling K; Pedersen M; Jensen MK; Andersen E; Pedersen NT; Mortensen LS
    J Clin Oncol; 1994 Aug; 12(8):1673-84. PubMed ID: 8040680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.